REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.73
-0.52 (-5.07%)
Jul 24, 2026, 4:00 PM EDT - Market closed
REGENXBIO Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 87.82 | 170.44 | 83.33 | 90.24 | 112.72 | 470.35 | |
Revenue Growth (YoY) | -43.96% | 104.54% | -7.66% | -19.94% | -76.03% | 204.30% |
Cost of Revenue | 27.94 | 20.3 | 33.57 | 37.21 | 54.55 | 51.83 |
Gross Profit | 59.89 | 150.14 | 49.76 | 53.03 | 58.18 | 418.51 |
Selling, General & Admin | 83.82 | 82.86 | 76.62 | 88.49 | 85.28 | 79.33 |
Research & Development | 232.55 | 228.3 | 208.52 | 232.27 | 242.45 | 181.44 |
Other Operating Expenses | 0.2 | 0.18 | -2.03 | 0.4 | -6.68 | -2.24 |
Total Operating Expenses | 316.57 | 311.34 | 283.11 | 321.16 | 321.06 | 258.53 |
Operating Income | -256.69 | -161.2 | -233.35 | -268.13 | -262.88 | 159.98 |
Interest Income | 11.82 | 12.33 | 18.9 | 11.34 | 5.73 | 7.54 |
Interest Expense | -45.15 | -45.01 | -12.66 | -6.86 | -23.25 | -26.28 |
Total Non-Operating Income (Expense) | -33.33 | -32.68 | 6.24 | 4.48 | -17.53 | -18.73 |
Pretax Income | -290.01 | -193.88 | -227.1 | -263.65 | -280.41 | 141.25 |
Provision for Income Taxes | - | - | - | -0.15 | -0.08 | 13.41 |
Net Income | -290.01 | -193.88 | -227.1 | -263.49 | -280.32 | 127.84 |
Net Income to Common | -290.01 | -193.88 | -227.1 | -263.49 | -280.32 | 127.84 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 52 | 52 | 50 | 44 | 43 | 42 |
Shares Outstanding (Diluted) | 52 | 52 | 50 | 44 | 43 | 44 |
Shares Change (YoY) | 1.79% | 4.17% | 13.21% | 1.35% | -1.73% | 17.79% |
EPS (Basic) | -5.60 | -3.76 | -4.59 | -6.02 | -6.50 | 3.01 |
EPS (Diluted) | -5.60 | -3.76 | -4.59 | -6.02 | -6.50 | 2.91 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -236.4 | -126.38 | -175.56 | -228.37 | -238.21 | 134.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -4.56 | -2.45 | -3.55 | -5.22 | -5.52 | 3.07 |
Gross Margin | 68.19% | 88.09% | 59.72% | 58.76% | 51.61% | 88.98% |
Operating Margin | -292.28% | -94.58% | -280.03% | -297.12% | -233.20% | 34.01% |
Profit Margin | -330.23% | -113.75% | -272.54% | -291.99% | -248.68% | 27.18% |
FCF Margin | -269.18% | -74.15% | -210.69% | -253.06% | -211.32% | 28.64% |
EBITDA | -241.17 | -145.58 | -217.13 | -250.81 | -249.97 | 169.54 |
EBITDA Margin | -274.61% | -85.42% | -260.57% | -277.93% | -221.75% | 36.05% |
EBIT | -256.69 | -161.2 | -233.35 | -268.13 | -262.88 | 159.98 |
EBIT Margin | -292.28% | -94.58% | -280.03% | -297.12% | -233.20% | 34.01% |
Effective Tax Rate | - | 0.00% | 0.00% | 0.06% | 0.03% | 9.49% |